BIOMAT Database Logo BIOMAT Database Logo

Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial. 2014

Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Department of Elderly, Vincent van Gogh Institute, Venray, The Netherlands; Department of Geriatric Medicine and Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: amirahmed1@hotmail.com.

There is a great concern about the safety of THC-based drugs in older people (≥65 years), as most of THC-trials did not include such group. In this phase 1, randomized, double-blind, double-dummy, placebo-controlled, cross-over trial, we evaluated the safety and pharmacokinetics of three oral doses of Namisol(®), a novel THC in tablet form, in older subjects. Twelve healthy older subjects (6 male; mean age 72±5 years) randomly received a single oral dose of 3mg, 5mg, or 6.5mg of THC or matching placebo, in a crossover manner, on each intervention day. The data for 11 subjects were included in the analysis. The data of 1 subject were excluded due to non-compliance to study medication. THC was safe and well tolerated. The most frequently reported adverse events (AEs) were drowsiness (27%) and dry mouth (11%). Subjects reported more AEs with THC 6.5mg than with 3mg (p=0.048), 5mg (p=0.034) and placebo (p=0.013). There was a wide inter-individual variability in plasma concentrations of THC. Subjects for whom the Cmax fell within the sampling period (over 2h), Cmax was 1.42-4.57ng/mL and Tmax was 67-92min. The AUC0-2h (n=11) was 1.67-3.51ng/mL. Overall, the pharmacodynamic effects of THC were smaller than effects previously reported in young adults. In conclusion, THC appeared to be safe and well tolerated by healthy older individuals. Data on safety and effectiveness of THC in frail older persons are urgently required, as this population could benefit from the therapeutic applications of THC.

UI MeSH Term Description Entries
D008297 Male Males
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
[Delta-9-tetrahydrocannabinol pharmacokinetics].
August 2008, Annales pharmaceutiques francaises,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
August 2006, Therapeutic drug monitoring,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial.
November 2015, Anesthesia and analgesia,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects.
July 2007, Clinical pharmacology and therapeutics,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects.
January 1977, The American review of respiratory disease,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Insulin Administration in Healthy Subjects: A Randomized, Double-Blind, Phase 1 Trial.
May 2022, Clinical pharmacology in drug development,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.
January 2020, Frontiers in psychiatry,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects.
May 2024, Diabetes, obesity & metabolism,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial.
December 2023, Antimicrobial agents and chemotherapy,
Amir I A Ahmed, and Geke A H van den Elsen, and Angela Colbers, and Marjolein A van der Marck, and David M Burger, and Ton B Feuth, and Marcel G M Olde Rikkert, and Cornelis Kramers
A randomized, controlled single, and multiple ascending dose trial of the safety, pharmacokinetics and pharmacodynamics of SN1011 in healthy subjects.
October 2023, Clinical and translational science,
Copied contents to your clipboard!